Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)
Clinical trial NCT07443202 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07443202
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-05
- Primary completion
- 2026-12-31
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.